AXON Stock Analysis: Axon Enterprise | NASDAQ

Aerospace & Defense | NASDAQ, USA | Market Cap: 25.686m USD | 12M Return: -43.7% | US05464C1018 | Charts, Fundamentals & Technical Analysis

Body Cameras, Stun Devices, Evidence Software, Drones
Total Rating 21
Safety 84
Buy Signal -1.11
Aerospace & Defense
Sub-Industry Rotation: +6.1
Market Cap: 25.7B
Avg Turnover: 486M
Risk 3d forecast
Volatility58.3%
VaR 5th Pctl7.93%
VaR vs Median-11.4%
Reward TTM
Sharpe Ratio-0.63
Rel. Str. IBD2.8
Rel. Str. Peer Group8.2 pctl
Character TTM
Beta1.353
Beta Downside1.306
Hurst Exponent0.651
Choppyness31.8%
Drawdowns 3y
Max DD65.72%
CAGR/Max DD0.15
CAGR/Mean DD0.49
EPS (Earnings per Share) EPS (Earnings per Share) of AXON over the last years for every Quarter: "2021-09": 1.17, "2021-12": 0.46, "2022-03": 0.45, "2022-06": 0.44, "2022-09": 0.6, "2022-12": 0.7, "2023-03": 0.88, "2023-06": 1.11, "2023-09": 1.02, "2023-12": 1.12, "2024-03": 1.15, "2024-06": 1.2, "2024-09": 1.45, "2024-12": 2.08, "2025-03": 1.41, "2025-06": 2.12, "2025-09": 1.17, "2025-12": 2.15, "2026-03": 1.61, "2026-06": 0.57, "2026-09": 0.29,
EPS CAGR: 12.81%
EPS Trend: 53.9%
Last SUE: -0.42
Qual. Beats: 0
Revenue Revenue of AXON over the last years for every Quarter: 2021-09: 231.989, 2021-12: 217.578, 2022-03: 256.426, 2022-06: 285.613, 2022-09: 311.754, 2022-12: 336.142, 2023-03: 343.043, 2023-06: 374.605, 2023-09: 413.278, 2023-12: 430.376, 2024-03: 459.871, 2024-06: 503.236, 2024-09: 544.274, 2024-12: 575.145, 2025-03: 603.633, 2025-06: 668.538, 2025-09: 710.641, 2025-12: 796.724, 2026-03: 807.345, 2026-06: 904.389, 2026-09: 908.554,
Rev. CAGR: 33.17%
Rev. Trend: 100.0%
Last SUE: -2.16
Qual. Beats: -1

Warnings

P/E Ratio 101.4
Favorite
Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.1% 0
Feb +3.6% 14
Mar -1.9% 4
Apr -0.4% 0
May +1.3% 4
Jun +4.6% 14
Jul -3.5% 4
Aug -1.3% 4
Sep -2.7% 28
Oct +2.4% 14
Nov +10.8% 9
Dec -2.1% 21

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: AXON Axon Enterprise

Axon Enterprise, Inc. (NASDAQ: AXON) is a U.S.-based public safety technology company headquartered in Scottsdale, Arizona, operating through two main segments: Software and Services, and Connected Devices. The Software and Services segment offers cloud-based SaaS platforms for capturing, storing, and analyzing digital evidence, including products such as Axon Evidence, Draft One, Axon Records, and Axon Fusus. The Connected Devices segment produces hardware such as TASER conducted energy devices, body-worn and in-car cameras, drone and counter-drone systems, and virtual reality training equipment.

The company sells to a diverse customer base that includes federal, state, and local law enforcement agencies, international government entities, commercial enterprises, and consumers, using a mix of direct sales, distribution partners, and third-party resellers. Originally incorporated in 1993 and formerly known as TASER International, the company rebranded to Axon Enterprise in April 2017 to reflect its expansion beyond conducted energy weapons into a broader integrated software and hardware ecosystem for first responders.

Axon is classified under the GICS Industrials sector and Aerospace & Defense sub-industry, though its primary end market is law enforcement and public safety rather than traditional military defense. A key feature of its business model is the recurring revenue generated through its SaaS subscriptions and evidence-management platforms, which complement the one-time hardware sales of TASER devices and cameras and support customer retention across agency lifecycles.

Headlines to Watch Out For
  • Software and Services segment drives recurring revenue growth
  • TASER and body camera demand strengthens from US law enforcement
  • International expansion and drone counter-drone adoption accelerate
  • Federal and state government budget cycles impact order timing
Piotroski VR-10 (Strict) 3.5
Net Income: 258.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.26 > 1.0
NWC/Revenue: 83.56% < 20% (prev 112.1%; Δ -28.52% < -1%)
CFO/TA 0.03 > 3% & CFO 225.5m > Net Income 258.7m
Net Debt (1.41b) to EBITDA (564.7m): 2.51 < 3
Current Ratio: 3.00 > 1.5 & < 3
Outstanding Shares: last quarter (83.7m) vs 12m ago 6.70% < -2%
Gross Margin: 58.53% > 18% (prev 60.31%; Δ -1.78% > 0.5%)
Asset Turnover: 44.12% > 50% (prev 38.42%; Δ 5.70% > 0%)
Interest Coverage Ratio: 3.78 > 6 (EBIT TTM 430.7m / Interest Expense TTM 113.9m)
Altman Z'' 3.71
A: 0.32 (Total Current Assets 4.28b - Total Current Liabilities 1.43b) / Total Assets 8.83b
B: 0.13 (Retained Earnings 1.19b / Total Assets 8.83b)
C: 0.06 (EBIT TTM 430.7m / Avg Total Assets 7.75b)
D: 0.74 (Book Value of Equity 3.76b / Total Liabilities 5.07b)
Altman-Z'' = 3.71 = AA
Beneish M -2.57
DSRI: 0.90 (Receivables 838.3m/700.7m, Revenue 3.42b/2.56b)
GMI: 1.03 (GM 60.31% / 58.53%)
AQI: 1.46 (AQ_t 0.47 / AQ_t-1 0.32)
SGI: 1.34 (Revenue 3.42b / 2.56b)
TATA: 0.00 (NI 258.7m - CFO 225.5m) / TA 8.83b)
Beneish M = -2.57 (Cap -4..+1) = A
What is the price of AXON shares?

As of November 19, 2026, the stock is trading at USD 300.69 with a total of 1,208,086 shares traded. Over the past week, the price has changed by -4.67%, over one month by -21.51%, over three months by -51.49% and over the past year by -43.67%.

Current recommended Stop Loss: 276.50 (which is 8% or 1.1 ATR below the current price).

Is AXON a buy, sell or hold?

Axon Enterprise has received a consensus analysts rating of 4.29. Therefore, it is recommended to buy AXON.

  • StrongBuy: 9
  • Buy: 9
  • Hold: 3
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the AXON price?
Analysts Target Price 541.3 80%
Axon Enterprise (AXON) - Fundamental Data Overview as of 15 November 2026
Market Cap USD = 25.7b (25.7b USD * 1.0 USD.USD)
P/E Trailing = 101.4244
P/E Forward = 58.1395
P/S = 7.5172
P/B = 10.1547
P/EG = 2.1074
Revenue TTM = 3.42b USD
EBIT TTM = 430.7m USD
EBITDA TTM = 564.7m USD
Long Term Debt = 2.87b USD (from longTermDebt, last quarter)
Short Term Debt = 80.6m USD (from shortTermDebt, last fiscal year)
Debt = 3.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.9m
Net Debt = 1.41b USD (calculated: Debt 3.07b - CCE 1.66b)
Enterprise Value = 27.1b USD (25.7b + Debt 3.07b - CCE 1.66b)
Interest Coverage Ratio = 3.78 (Ebit TTM 430.7m / Interest Expense TTM 113.9m)
EV/FCF = 334.9x (Enterprise Value 27.1b / FCF TTM 80.9m)
FCF Yield = 0.30% (FCF TTM 80.9m / Enterprise Value 27.1b)
FCF Margin = 2.37% (FCF TTM 80.9m / Revenue TTM 3.42b)
Net Margin = 7.57% (Net Income TTM 258.7m / Revenue TTM 3.42b)
Gross Margin = 58.53% ((Revenue TTM 3.42b - Cost of Revenue TTM 1.42b) / Revenue TTM)
Gross Margin QoQ = 56.68% (prev 60.42%)
Tobins Q-Ratio = 3.07 (Enterprise Value 27.1b / Total Assets 8.83b)
Interest Expense / Debt = 3.71% (Interest Expense 113.9m / Debt 3.07b)
Taxrate = 18.33% (58.1m / 316.8m)
NOPAT = 351.8m (EBIT 430.7m * (1 - 18.33%))
Current Ratio = 3.00 (Total Current Assets 4.28b / Total Current Liabilities 1.43b)
Debt / Equity = 0.82 (Debt 3.07b / totalStockholderEquity, last quarter 3.76b)
Debt / EBITDA = 2.51 (Net Debt 1.41b / EBITDA 564.7m)
Debt / FCF = 17.48 (Net Debt 1.41b / FCF TTM 80.9m)
Total Stockholder Equity = 3.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.34% (Net Income 258.7m / Total Assets 8.83b)
RoE = 7.28% (Net Income TTM 258.7m / Total Stockholder Equity 3.55b)
RoCE = 6.71% (EBIT 430.7m / Capital Employed (Equity 3.55b + L.T.Debt 2.87b))
RoIC = 4.81% (NOPAT 351.8m / Invested Capital 7.32b)
WACC = 9.42% (E(25.7b)/V(28.8b) * Re(10.18%) + D(3.07b)/V(28.8b) * Rd(3.71%) * (1-Tc(0.18)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 41.44 | Cagr: 3.44%
[DCF] Terminal Value 69.21% ; FCFF base≈106.6m ; Y1≈93.4m ; Y5≈75.5m
 [DCF] Fair Price = N/A (negative equity: EV 1.03b - Net Debt 1.41b = -383.8m; debt exceeds intrinsic value)
 EPS Correlation: 53.89 | EPS CAGR: 12.81% | SUE: -0.42 | # QB: 0
Revenue Correlation: 99.99 | Revenue CAGR: 33.17% | SUE: -2.16 | # QB: -1
EPS current Quarter (2027-03-31): EPS=1.93 | Chg30d=-12.37% | Revisions=-77% | Analysts=16
EPS current Year (2026-12-31): EPS=7.11 | Chg30d=-7.04% | Revisions=-47% | GrowthEPS=+3.8% | GrowthRev=+30.4%
EPS next Year (2027-12-31): EPS=9.44 | Chg30d=-10.43% | Revisions=-71% | GrowthEPS=+32.9% | GrowthRev=+27.5%
[Analyst] Revisions Ratio: -73% (up=4, down=34)